Bronchopulmonary dysplasia (BPD) remains the most common respiratory complication of
prematurity as younger and smaller infants are surviving beyond the immediate neonatal …

While perinatal medicine advancements have bolstered survival outcomes for premature
infants, bronchopulmonary dysplasia (BPD) continues to threaten their long-term health …

Importance The ability to identify poor outcomes and treatable risk factors among very
preterm infants remains challenging; improving early risk detection and intervention targets …

Bronchopulmonary dysplasia (BPD) is a prevalent chronic lung disease of prematurity with
limited treatment options. To uncover biomarkers of BPD risk, this study investigated …

Importance Very preterm neonates (24-32 weeks' gestation) remain at a higher risk of
morbidity and neurodevelopmental adversity throughout their lifespan. Because the extent of …

Background Bronchopulmonary dysplasia (BPD) is a lung disease in premature infants
caused by therapeutic oxygen supplemental and characterized by impaired pulmonary …

Background Preterm birth is closely associated with a phenotype that includes brain
dysmaturation and neurocognitive impairment, commonly termed Encephalopathy of …

Abstract The National Institutes of Health's Environmental influences on Child Health
Outcomes (ECHO) Program was designed to address solution-oriented research questions …

Background Bronchopulmonary dysplasia (BPD), a common morbidity among very preterm
infants, is associated with chronic disease and neurodevelopmental impairments. A …

Preterm birth is associated with dysconnectivity of structural brain networks and is a leading
cause of neurocognitive impairment in childhood. Variation in DNA methylation is …